Page last updated: 2024-10-31

nocodazole and von Hippel-Lindau Disease

nocodazole has been researched along with von Hippel-Lindau Disease in 2 studies

von Hippel-Lindau Disease: An autosomal dominant disorder caused by mutations in a tumor suppressor gene. This syndrome is characterized by abnormal growth of small blood vessels leading to a host of neoplasms. They include HEMANGIOBLASTOMA in the RETINA; CEREBELLUM; and SPINAL CORD; PHEOCHROMOCYTOMA; pancreatic tumors; and renal cell carcinoma (see CARCINOMA, RENAL CELL). Common clinical signs include HYPERTENSION and neurological dysfunctions.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thoma, CR1
Matov, A1
Gutbrodt, KL1
Hoerner, CR1
Smole, Z1
Krek, W2
Danuser, G1
Hergovich, A1
Lisztwan, J1
Barry, R1
Ballschmieter, P1

Other Studies

2 other studies available for nocodazole and von Hippel-Lindau Disease

ArticleYear
Quantitative image analysis identifies pVHL as a key regulator of microtubule dynamic instability.
    The Journal of cell biology, 2010, Sep-20, Volume: 190, Issue:6

    Topics: Amino Acid Sequence; Cluster Analysis; Green Fluorescent Proteins; Guanosine Triphosphate; Humans; H

2010
Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL.
    Nature cell biology, 2003, Volume: 5, Issue:1

    Topics: Animals; Chlorocebus aethiops; COS Cells; Genes, Tumor Suppressor; HeLa Cells; Humans; Kinetics; Lig

2003